Cargando…

Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis

Background: Head and neck squamous cell carcinoma (HNSCC) exists within a microenvironment rich in immune cells. Macrophages are particularly abundant in and around tumor tissue, and have been implicated in the growth, malignancy, and persistence of HNSCC (1). However, current literature reports var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Ayan Tyagi, Knops, Alexander, Swendseid, Brian, Martinez-Outschoom, Ubaldo, Harshyne, Larry, Philp, Nancy, Rodeck, Ulrich, Luginbuhl, Adam, Cognetti, David, Johnson, Jennifer, Curry, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663973/ https://www.ncbi.nlm.nih.gov/pubmed/31396482 http://dx.doi.org/10.3389/fonc.2019.00656

Ejemplares similares

Cancer-Associated Fibroblast Density, Prognostic Characteristics, and Recurrence in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Knops, Alexander M., et al.
Publicado: (2020)

Metformin Clinical Trial in HPV+ and HPV– Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate
por: Curry, Joseph M., et al.
Publicado: (2018)

Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma
por: Luginbuhl, Adam J., et al.
Publicado: (2022)

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
por: Johnson, Jennifer M, et al.
Publicado: (2023)

Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment Effect
por: Merlino, Dante J., et al.
Publicado: (2020)

Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes
por: Topf, Michael C., et al.
Publicado: (2017)

Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
por: Curry, Joseph, et al.
Publicado: (2017)

Outcomes of Venous End‐to‐Side Microvascular Anastomoses of the Head and Neck
por: Stewart, Matthew, et al.
Publicado: (2020)

Carotid dosimetry after re-irradiation with (131)Cs permanent implant brachytherapy in recurrent, resected head and neck cancer
por: Walsh, Amanda, et al.
Publicado: (2019)

miRNA- and cytokine-associated extracellular vesicles mediate squamous cell carcinomas
por: Flemming, Joseph P., et al.
Publicado: (2020)

A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery
por: Rodin, Julianna, et al.
Publicado: (2018)

Single institution implementation of permanent (131)Cs interstitial brachytherapy for previously irradiated patients with resectable recurrent head and neck carcinoma
por: Bar-Ad, Voichita, et al.
Publicado: (2019)

Preoperative Immunotherapy in the Multidisciplinary Management of Oral Cavity Cancer
por: Philips, Ramez, et al.
Publicado: (2021)

Percutaneous gastrostomy site metastasis from head and neck tumors: A single institution case series
por: Metkus, James S., et al.
Publicado: (2017)

Head and neck surgery global outreach: Ethics, planning, and impact
por: Luginbuhl, Adam, et al.
Publicado: (2021)

Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma
por: Fertig, Elana J, et al.
Publicado: (2012)

Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
por: Curry, Joseph M., et al.
Publicado: (2013)

Thyroid Cancer Metabolism: A Review
por: Gill, Kurren S, et al.
Publicado: (2016)

Preoperative cephalometric analysis to predict transoral robotic surgery exposure
por: Luginbuhl, Adam, et al.
Publicado: (2014)

Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
por: Luginbuhl, Adam, et al.
Publicado: (2021)

Impact of adjuvant radiation therapy after definitive surgery in senior adults >80 years old with advanced head and neck squamous cell carcinoma on overall survival
por: Butkus, Joann M., et al.
Publicado: (2022)

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
por: Crist, McKenzie, et al.
Publicado: (2022)

Postoperative analysis of osseous midface reconstructions: The value of imaging and a novel scoring system for complexity and operative success
por: Swendseid, Brian, et al.
Publicado: (2022)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Involvement of extracellular vesicles in the macrophage-tumor cell communication in head and neck squamous cell carcinoma
por: Bellmunt, Àngela Maria, et al.
Publicado: (2019)

Comprehensive analysis of macrophage-related multigene signature in the tumor microenvironment of head and neck squamous cancer
por: Lin, Bo, et al.
Publicado: (2021)

Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer
por: Bisetto, Sara, et al.
Publicado: (2018)

Tumor-associated macrophages derived CCL18 promotes metastasis in squamous cell carcinoma of the head and neck
por: She, Li, et al.
Publicado: (2018)

Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma
por: Kindt, Nadège, et al.
Publicado: (2019)

Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma
por: Wang, Sha-sha, et al.
Publicado: (2016)

FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma
por: Liang, Huazhen, et al.
Publicado: (2021)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma
por: Cognetti, David M., et al.
Publicado: (2021)

Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients
por: Bryant, Lucas M., et al.
Publicado: (2018)

Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
por: Bovenzi, Cory D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_15esjlb2knaiovsr4vmn2g6rd2